U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H23NO
Molecular Weight 281.392
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BLARCAMESINE

SMILES

CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=BOTHKNZTGGXFEQ-UHFFFAOYSA-N
InChI=1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C19H23NO
Molecular Weight 281.392
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:51:02 UTC 2023
Edited
by admin
on Sat Dec 16 15:51:02 UTC 2023
Record UNII
9T210MMZ3F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BLARCAMESINE
INN   USAN  
Official Name English
ANAVEX 2-73
Code English
RAC-1-((3R)-2,2-DIPHENYLOXOLAN-3-YL)-N,N-DIMETHYLMETHANAMINE
Systematic Name English
blarcamesine [INN]
Common Name English
BLARCAMESINE [USAN]
Common Name English
3-FURANMETHANAMINE, TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-
Systematic Name English
TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 908022
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
Code System Code Type Description
INN
11031
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
USAN
FG-91
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
PUBCHEM
9882189
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
NCI_THESAURUS
C171846
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
EVMPD
SUB197746
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
SMS_ID
100000183265
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
CAS
195615-83-9
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
EPA CompTox
DTXSID60941344
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
FDA UNII
9T210MMZ3F
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
WIKIPEDIA
Blarcamesine
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
DRUG BANK
DB05592
Created by admin on Sat Dec 16 15:51:03 UTC 2023 , Edited by admin on Sat Dec 16 15:51:03 UTC 2023
PRIMARY
Related Record Type Details
SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1
TARGET -> AGONIST
MUSCARINIC ACETYLCHOLINE RECEPTOR M1
TARGET->MODULATOR
Structure of BLARCAMESINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of BLARCAMESINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966